Blue Mountain Pharmaceutical Industries Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 0.94 M
as on 03-07-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Blue Mountain Pharmaceutical Industries
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.94 M, as per Ministry of Corporate Affairs (MCA) records.
Anitha Ilango and Ilango Vetrivel serve as directors at the Company.
- CIN/LLPIN
U68100TN2021PTC143329
- Company No.
143329
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2021
- Date of AGM
24 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tuticorin, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Blue Mountain Pharmaceutical Industries?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anitha Ilango  | Director | 07-May-2021 | Current |
| Ilango Vetrivel | Director | 07-May-2021 | Current |
Financial Performance of Blue Mountain Pharmaceutical Industries.
Enhance accessibility to Blue Mountain Pharmaceutical Industries's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Blue Mountain Pharmaceutical Industries?
Unlock access to Blue Mountain Pharmaceutical Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
The Tuticorin Spinning Mills LimitedActive 78 years 5 monthsAnitha Ilango and Ilango Vetrivel are mutual person
Osd Hrc Pipeline Engineers Private LimitedActive 14 years 10 monthsAnitha Ilango and Ilango Vetrivel are mutual person
Hydrocarbon Project Engineers LimitedActive 19 years 2 monthsAnitha Ilango and Ilango Vetrivel are mutual person
Tuticorin Peak Yarn Trading Company Private LimitedActive 34 years 9 monthsAnitha Ilango is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Blue Mountain Pharmaceutical Industries?
Blue Mountain Pharmaceutical Industries has a workforce of 4 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blue Mountain Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blue Mountain Pharmaceutical Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
